Faeth Therapeutics, Inc. FTH · SEC Filings

website

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for...

Price12.68

Market Cap327.7 M

Float22.26 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

ATM | Offering amount: $7,371,339 | Amount sold to date: $0 | Float: 16,380,754

Aug 17, 2023

424B5

ATM | Offering amount: $50,000,000

May 9, 2022

424B4

7,000,052 Shares-

Feb 4, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 3, 2026

S-3ASR

June 2026 SHELF + ATM

Jun 18, 2026

S-3/A

SHARE RESALE REGISTRATION

Jun 10, 2026

S-3/A

SHARE RESALE REGISTRATION

Jun 2, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 15, 2026

S-3

SHARE RESALE REGISTRATION

Apr 28, 2026

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 22, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 21, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 27, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 27, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 16, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 11, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Parikh Anand Kiran (Reporting)

Nov 3, 2026

Schayowitz Adam (Reporting)

Oct 27, 2026

Schayowitz Adam (Reporting)

Oct 27, 2026

Vousden Karen H (Reporting)

Sep 15, 2026

Vousden Karen H (Reporting)

Sep 15, 2026

SCHEDULE 13G/A

Caligan Partners LP (Filed by)

Aug 14, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 15, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

May 10, 2022

CORRESP

Form CORRESP - Correspondence

May 6, 2022

CORRESP

Form CORRESP - Correspondence

May 6, 2022

CORRESP

Form CORRESP - Correspondence

May 4, 2022

LETTER

Form UPLOAD - SEC-generated letter

Mar 22, 2022